Catalyst Wire Dossier Catalyst Wire Dossier

Insulin aspart

insulin aspart · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

60 regulatory and trial events tracked for Insulin aspart, covering 2006-08-08 to 2026-06-05. Get the full timeline:

Most recent: EMA Application withdrawn: Insulin Aspart Injection (insulin aspart) — Masuu Pharma Europe Limited

See pricing